What does this research mean for the field?

Glutamine addiction in tumor cells, driven by metabolic reprogramming, creates specific vulnerabilities to regulated cell death that can be exploited for targeted cancer therapies. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review the biological functions of glutamine metabolism in cancer, emphasizing its influence on regulated cell death, tumor microenvironment modulation, and therapeutic drug development.

August 27, 2026Experimental Hematology and OncologyOpen Access

Unraveling the role of glutamine metabolism in cancer: from cell death mechanisms to tumor microenvironment modulation

View Full Paper

Ask AI

Bookmark

Authors

XPXintong Peng SLShuang Liu YTYongguang Tao

Discussion

Member takes

Overview

Review reveals how glutamine metabolism regulates cell death and alters the tumor microenvironment, highlighting novel therapeutic targets in oncology.

Key Points

To review the biological functions of glutamine metabolism in cancer, emphasizing its influence on regulated cell death, tumor microenvironment modulation, and therapeutic drug development.
Synthesized mechanistic and clinical literature regarding cancer metabolic reprogramming, glutamine utilization pathways, and regulated cell death cascades.
Evaluated the impact of glutamine metabolism on immune microenvironment components and cataloged anti-tumor drugs targeting glutamine pathways.
Metabolic reprogramming causes cancer cells to develop glutamine addiction, establishing both heightened survival adaptability and critical metabolic vulnerabilities.
Nutrient deprivation and altered glutamine flux directly modulate pathways of regulated cell death under cellular stress conditions.
Glutamine metabolism significantly influences the tumor immune microenvironment, supporting the therapeutic rationale for ongoing development of glutamine-targeted anticancer agents.

Cite This Study

Peng et al. (2026) studied this question.

synapsesocial.com/papers/6a8fe9b910c91c1e926219f6 https://doi.org/10.1186/s40164-026-00812-1

View Full Paper

Ask AI

Bookmark

August 27, 2026Experimental Hematology and OncologyOpen Access

Unraveling the role of glutamine metabolism in cancer: from cell death mechanisms to tumor microenvironment modulation

View Full Paper

Ask AI

Bookmark

Authors

XPXintong Peng SLShuang Liu YTYongguang Tao

Discussion

Member takes

Overview

Review reveals how glutamine metabolism regulates cell death and alters the tumor microenvironment, highlighting novel therapeutic targets in oncology.

Key Points

To review the biological functions of glutamine metabolism in cancer, emphasizing its influence on regulated cell death, tumor microenvironment modulation, and therapeutic drug development.
Synthesized mechanistic and clinical literature regarding cancer metabolic reprogramming, glutamine utilization pathways, and regulated cell death cascades.
Evaluated the impact of glutamine metabolism on immune microenvironment components and cataloged anti-tumor drugs targeting glutamine pathways.
Metabolic reprogramming causes cancer cells to develop glutamine addiction, establishing both heightened survival adaptability and critical metabolic vulnerabilities.
Nutrient deprivation and altered glutamine flux directly modulate pathways of regulated cell death under cellular stress conditions.
Glutamine metabolism significantly influences the tumor immune microenvironment, supporting the therapeutic rationale for ongoing development of glutamine-targeted anticancer agents.

Cite This Study

Peng et al. (2026) studied this question.

synapsesocial.com/papers/6a8fe9b910c91c1e926219f6 https://doi.org/10.1186/s40164-026-00812-1

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark